Oncoinvent ASA (LON:0RU5)
London flag London · Delayed Price · Currency is GBP · Price in NOK
42.50
-0.06 (-0.13%)
Feb 10, 2026, 11:47 AM GMT

Oncoinvent ASA Income Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
14.352.730.060.070.360.2
Other Revenue
5.645.375.736.2210.7210.18
208.15.796.2811.0810.38
Revenue Growth (YoY)
247.12%39.95%-7.85%-43.31%6.80%-9.06%
Cost of Revenue
----0.90.46
Gross Profit
208.15.796.2810.199.91
Selling, General & Admin
46.9951.4455.7447.3437.5631.45
Other Operating Expenses
65.6483.1386.2261.5748.6633.88
Operating Expenses
127.75149.12153.22116.8991.0170.16
Operating Income
-107.76-141.02-147.43-110.61-80.83-60.25
Interest Expense
--0.08-0.01-0.01-0.01-0
Interest & Investment Income
1.471.344.414.440.750.88
Currency Exchange Gain (Loss)
-0.45-0.45-0.6-0.11--
Other Non Operating Income (Expenses)
0----0.210.16
Pretax Income
-106.73-140.2-143.62-106.28-80.29-59.22
Net Income
-106.73-140.2-143.62-106.28-80.29-59.22
Net Income to Common
-106.73-140.2-143.62-106.28-80.29-59.22
Shares Outstanding (Basic)
110000
Shares Outstanding (Diluted)
110000
Shares Change (YoY)
367.98%374.39%0.27%-2.42%38.93%8.47%
EPS (Basic)
-83.71-151.99-738.62-548.04-404.00-414.00
EPS (Diluted)
-83.71-151.99-738.62-548.04-404.00-414.00
Free Cash Flow
-85.6-89.75-164.94-93.17--
Free Cash Flow Per Share
-67.14-97.29-848.27-480.45--
Gross Margin
100.00%100.00%100.00%100.00%91.92%95.53%
Operating Margin
-538.89%-1740.31%-2546.20%-1760.48%-729.27%-580.61%
Profit Margin
-533.74%-1730.24%-2480.50%-1691.55%-724.43%-570.67%
Free Cash Flow Margin
-428.09%-1107.55%-2848.72%-1482.94%--
EBITDA
-98.87-131.81-139.84-105.82-76.04-55.42
D&A For EBITDA
8.899.27.594.794.794.83
EBIT
-107.76-141.02-147.43-110.61-80.83-60.25
Revenue as Reported
208.15.796.2811.0810.38
Advertising Expenses
----0.090.11
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.